Piermont Capital Management’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-42,660	Closed	-$878K	–	263
2016 Q3	$878K	Buy	42,660 +9,410	+28%	+$194K	0.21%	179
2016 Q2	$1.02M	Buy	33,250 +17,225	+107%	+$527K	0.26%	142
2016 Q1	$600K	Buy	16,025 +385	+2%	+$14.4K	0.19%	127
2015 Q4	$675K	Buy	+15,640	New	+$675K	0.21%	114